Get the Stockscreener App
3.25
11.68%
0.34
Tuhura Biosciences Inc stock is traded at $3.25, with a volume of 612.55K.
It is up +11.68% in the last 24 hours and up +18.61% over the past month.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
See More
Previous Close:
$2.91
Open:
$2.87
24h Volume:
612.55K
Relative Volume:
1.44
Market Cap:
$154.65M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.21%
1M Performance:
+18.61%
6M Performance:
-2.40%
1Y Performance:
+0.00%
1-Day Range:
$2.87
$3.30
1-Week Range:
$2.85
$3.30
52-Week Range:
$1.80
$7.20
Tuhura Biosciences Inc Stock (HURA) Company Profile
Name
Tuhura Biosciences Inc
Sector
Industry
Phone
813-875-6600
Address
10500 UNIVERSITY CENTER DR., TAMPA
Compare HURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
3.25 | 154.65M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-03-25 | Initiated | H.C. Wainwright | Buy |
| Dec-19-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-05-24 | Initiated | Maxim Group | Buy |
Tuhura Biosciences Inc Stock (HURA) Latest News
Trend Reversal Possible in TuHURA Biosciences Inc. Charts IndicateJuly 2025 PreEarnings & Fast Exit and Entry Strategy Plans - beatles.ru
Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight - GlobeNewswire Inc.
Analysts Weigh in on Healthcare Stocks: Venus Concept (VERO) and TuHURA Biosciences (HURA) - AInvest
TuHURA Biosciences Inc. Crosses 200 Day MA — Signal or NoiseJuly 2025 Snapshot & Detailed Earnings Play Alerts - mustnews.co.kr
TuHURA Biosciences, Inc. to Present at the 27th Annual H.C. Wainwright Global Investment Conference - Citizen Tribune
TuHURA Biosciences Inc. Builds Base for Possible ReboundShort Setup & Stepwise Entry and Exit Trade Signals - classian.co.kr
Is it time to cut losses on TuHURA Biosciences Inc.Weekly Loss Report & Free Fast Gain Swing Trade Alerts - Newser
Will breakout in TuHURA Biosciences Inc. lead to full recoveryJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - Newser
How to forecast TuHURA Biosciences Inc. trends using time seriesEarnings Recap Report & Low Drawdown Investment Ideas - Newser
How institutional ownership impacts TuHURA Biosciences Inc. stock2025 Analyst Calls & Precise Buy Zone Tips - Newser
Pattern recognition hints at TuHURA Biosciences Inc. upside2025 Growth vs Value & High Accuracy Buy Signal Tips - Newser
Combining machine learning predictions for TuHURA Biosciences Inc.Portfolio Gains Summary & Safe Entry Zone Identification - Newser
Using flow based indicators on TuHURA Biosciences Inc.2025 Fundamental Recap & Weekly High Momentum Picks - Newser
How to interpret RSI for TuHURA Biosciences Inc. stock2025 Short Interest & Target Return Focused Stock Picks - Newser
Top chart patterns to watch in TuHURA Biosciences Inc.2025 Fundamental Recap & Capital Protection Trading Alerts - Newser
Can TuHURA Biosciences Inc. deliver alpha2025 Top Gainers & Technical Entry and Exit Alerts - 선데이타임즈
TuHURA Biosciences Inc. stock trend forecast2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Tools to assess TuHURA Biosciences Inc.’s risk profileWeekly Investment Recap & Weekly Top Stock Performers List - Newser
How Resilient Is TuHURA Biosciences Inc. Stock During Economic DownturnsJuly 2025 Action & Risk Managed Trade Strategies - Newser
TuHURA Biosciences Advances Clinical Trials and Strengthens Market Position - MSN
Published on: 2025-08-15 06:47:15 - Newser
TuHURA R&D Jumps 75% in Q2 - sharewise.com
TuHURA Biosciences Posts 75% R&D Jump in Q2, Begins Pivotal Phase 3 Trial for IFx-2.0 Under FDA Agreement - AInvest
TuHURA Biosciences: Pioneering Immuno-Oncology Innovation Amid Accelerating Regulatory and Financial Momentum - AInvest
TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - PR Newswire
TuHURA Biosciences Soars 13.73% on Bullish Sentiment - AInvest
TuHURA Biosciences Inc. stock prediction for this weekWeekly Market Outlook & Stepwise Trade Signal Implementation - Newser
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Average Rating of “Buy” from Brokerages - Defense World
Relative strength of TuHURA Biosciences Inc. in sector analysisJuly 2025 Patterns & Reliable Momentum Entry Alerts - Newser
Published on: 2025-08-13 01:18:18 - Newser
Order flow analysis tools used on TuHURA Biosciences Inc.Dividend Hike & AI Optimized Trading Strategy Guides - Newser
HURA Biosciences (HURA.O) Surges 10.8% Intraday—What's Behind the Unusual Move? - AInvest
Unpacking the Sharp Rally in TuHURA Biosciences (HURA.O): A Technical and Order-Flow Deep Dive - AInvest
TuHURA Biosciences Surges Over 12% Despite No Clear Fundamentals — What’s Driving the Move? - AInvest
Published on: 2025-08-12 04:42:02 - Newser
TuHURA Biosciences (NASDAQ:HURA) Stock Acquired Rep. Laurel M. Lee - Defense World
U.S. politician makes a rare, super suspicious stock trade - Finbold
HURA's 30% Surge: Technical Catalysts and Sector Divergence Ignite Biotech Speculation - AInvest
TuHURA Biosciences (HURA) Surges 35% Intraday: Retail Frenzy or Technical Reversal? - AInvest
Visual analytics tools that track TuHURA Biosciences Inc. performanceWeekly Gain Forecast with Momentum Indicators - Newser
TuHURA Biosciences' Retail Investors Take the Brunt of the 11% Decline - AInvest
TuHURA Biosciences, Inc.'s (NASDAQ:HURA) last week's 11% decline must have disappointed retail investors who have a significant stake - Yahoo Finance
Applying sector rotation models to TuHURA Biosciences Inc.Free Breakout Confirmation With Entry Tracker - Newser
TuHURA Biosciences Inc. Building a Base Near SupportWeekly Stock Watch With Growth Focus Expanded - beatles.ru
Can volume confirm reversal in TuHURA Biosciences Inc.Volatility Analysis and Entry Risk Mapping - Newser
TuHURA Biosciences and Kineta stockholders approve proposed deal - MSN
Order Flow Trends Show Accumulation in TuHURA Biosciences Inc.Entry Zone Strategy for Consistent Profit Shared - beatles.ru
Is TuHURA Biosciences Inc. a growth stock or a value stockDiscover stocks with explosive potential - Jammu Links News
How many analysts rate TuHURA Biosciences Inc. as a “Buy”Exponential return rates - Jammu Links News
What institutional investors are buying TuHURA Biosciences Inc. stockCapitalize on fast-growing stocks today - Jammu Links News
TuHURA Biosciences Inc. Stock Analysis and ForecastDiscover the fastest growing stocks today - Jammu Links News
Tuhura Biosciences Inc Stock (HURA) Financials Data
There is no financial data for Tuhura Biosciences Inc (HURA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):